PortfoliosLab logoPortfoliosLab logo
iHuman Inc. (IH)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US45175B1098
CUSIP
45175B109
IPO Date
Oct 9, 2020

Highlights

Market Cap
$18.22M
Enterprise Value
-$52.35M
EPS (TTM)
$8.22
PE Ratio
0.21
PEG Ratio
0.02
Total Revenue (TTM)
$672.03M
Gross Profit (TTM)
$455.61M
EBITDA (TTM)
$59.08M
Year Range
$1.67 - $3.60
ROA (TTM)
45.74%
ROE (TTM)
63.64%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


iHuman Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in iHuman Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

iHuman Inc. (IH) has returned -18.82% so far this year and -15.20% over the past 12 months.


iHuman Inc.

1D
1.49%
1M
-1.45%
YTD
-18.82%
6M
-41.00%
1Y
-15.20%
3Y*
-16.26%
5Y*
-32.34%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 9, 2020, IH's average daily return is -0.03%, while the average monthly return is -1.49%.

Historically, 50% of months were positive and 50% were negative. The best month was Nov 2020 with a return of +55.9%, while the worst month was Dec 2020 at -35.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, IH closed higher 45% of trading days. The best single day was Oct 12, 2020 with a return of +40.3%, while the worst single day was Mar 14, 2022 at -33.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-12.45%-5.92%-1.45%-18.82%
20251.78%19.19%3.41%6.43%11.21%5.04%20.00%-6.83%3.40%-2.42%1.06%-26.31%31.03%
2024-20.20%-17.14%-11.36%1.47%17.10%-11.39%-12.29%4.46%40.24%-22.61%-7.30%2.42%-41.73%
202336.15%-17.23%10.58%-2.19%-20.48%17.46%8.45%-11.53%6.34%-14.57%6.59%11.64%18.08%
2022-5.36%-15.09%-4.89%40.65%-16.94%-5.60%-0.42%-14.89%10.00%-10.91%1.53%30.65%-7.14%
20211.77%0.33%-32.38%2.32%-30.00%15.40%-33.85%0.29%-31.34%6.16%-17.80%-31.87%-84.55%

Benchmark Metrics

iHuman Inc. has an annualized alpha of -13.63%, beta of 0.64, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 12, 2020.

  • This stock participated in 97.71% of S&P 500 Index downside but only -52.28% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.64 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-13.63%
Beta
0.64
0.02
Upside Capture
-52.28%
Downside Capture
97.71%

Return for Risk

Risk / Return Rank

IH ranks 27 for risk / return — below 27% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


IH Risk / Return Rank: 2727
Overall Rank
IH Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
IH Sortino Ratio Rank: 3030
Sortino Ratio Rank
IH Omega Ratio Rank: 2929
Omega Ratio Rank
IH Calmar Ratio Rank: 2525
Calmar Ratio Rank
IH Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for iHuman Inc. (IH) and compare them to a chosen benchmark (S&P 500 Index).


IHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.25

0.90

-1.14

Sortino ratio

Return per unit of downside risk

0.04

1.39

-1.34

Omega ratio

Gain probability vs. loss probability

1.01

1.21

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.49

1.40

-1.89

Martin ratio

Return relative to average drawdown

-0.98

6.61

-7.58

Explore IH risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

iHuman Inc. provided a 5.87% dividend yield over the last twelve months, with an annual payout of $0.10 per share.


4.80%5.00%5.20%5.40%5.60%5.80%6.00%$0.00$0.02$0.04$0.06$0.08$0.1020242025
Dividends
Dividend Yield
PeriodTTM20252024
Dividend$0.10$0.10$0.10

Dividend yield

5.87%4.76%5.92%

Monthly Dividends

The table displays the monthly dividend distributions for iHuman Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.10$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.10
2024$0.10$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.10

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the iHuman Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the iHuman Inc. was 95.95%, occurring on Mar 14, 2022. The portfolio has not yet recovered.

The current iHuman Inc. drawdown is 93.63%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.95%Nov 24, 2020327Mar 14, 2022
-38.75%Oct 14, 20206Oct 21, 202023Nov 23, 202029

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of iHuman Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how iHuman Inc. is priced in the market compared to other companies in the Education & Training Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for IH, comparing it with other companies in the Education & Training Services industry. Currently, IH has a P/E ratio of 0.2. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for IH compared to other companies in the Education & Training Services industry. IH currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for IH relative to other companies in the Education & Training Services industry. Currently, IH has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for IH in comparison with other companies in the Education & Training Services industry. Currently, IH has a P/B value of 0.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items